Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Bile salt enhancers for inhalation : Correlation between in vitro and in vivo lung effects. / Sorli, Jorid B.; Sivars, Kinga Balogh; Da Silva, Emilie; Hougaard, Karin S.; Koponen, Ismo K.; Zuo, Yi Y.; Weydahl, Ingrid E. K.; Aberg, Per M.; Fransson, Rebecca.

In: International Journal of Pharmaceutics, Vol. 550, No. 1-2, 2018, p. 114-122.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Sorli, JB, Sivars, KB, Da Silva, E, Hougaard, KS, Koponen, IK, Zuo, YY, Weydahl, IEK, Aberg, PM & Fransson, R 2018, 'Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects', International Journal of Pharmaceutics, vol. 550, no. 1-2, pp. 114-122. https://doi.org/10.1016/j.ijpharm.2018.08.031

APA

Sorli, J. B., Sivars, K. B., Da Silva, E., Hougaard, K. S., Koponen, I. K., Zuo, Y. Y., ... Fransson, R. (2018). Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects. International Journal of Pharmaceutics, 550(1-2), 114-122. https://doi.org/10.1016/j.ijpharm.2018.08.031

Vancouver

Sorli JB, Sivars KB, Da Silva E, Hougaard KS, Koponen IK, Zuo YY et al. Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects. International Journal of Pharmaceutics. 2018;550(1-2):114-122. https://doi.org/10.1016/j.ijpharm.2018.08.031

Author

Sorli, Jorid B. ; Sivars, Kinga Balogh ; Da Silva, Emilie ; Hougaard, Karin S. ; Koponen, Ismo K. ; Zuo, Yi Y. ; Weydahl, Ingrid E. K. ; Aberg, Per M. ; Fransson, Rebecca. / Bile salt enhancers for inhalation : Correlation between in vitro and in vivo lung effects. In: International Journal of Pharmaceutics. 2018 ; Vol. 550, No. 1-2. pp. 114-122.

Bibtex

@article{53426f63882747fcb107fa1e692f5146,
title = "Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects",
keywords = "Lung surfactant, Constrained drop surfactometer, Inhaled pharmaceutical enhancer, Bile salt, 3D human airway in vitro model, MucilAir (TM), Alternative method",
author = "Sorli, {Jorid B.} and Sivars, {Kinga Balogh} and {Da Silva}, Emilie and Hougaard, {Karin S.} and Koponen, {Ismo K.} and Zuo, {Yi Y.} and Weydahl, {Ingrid E. K.} and Aberg, {Per M.} and Rebecca Fransson",
year = "2018",
doi = "10.1016/j.ijpharm.2018.08.031",
language = "English",
volume = "550",
pages = "114--122",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

RIS

TY - JOUR

T1 - Bile salt enhancers for inhalation

T2 - Correlation between in vitro and in vivo lung effects

AU - Sorli, Jorid B.

AU - Sivars, Kinga Balogh

AU - Da Silva, Emilie

AU - Hougaard, Karin S.

AU - Koponen, Ismo K.

AU - Zuo, Yi Y.

AU - Weydahl, Ingrid E. K.

AU - Aberg, Per M.

AU - Fransson, Rebecca

PY - 2018

Y1 - 2018

KW - Lung surfactant

KW - Constrained drop surfactometer

KW - Inhaled pharmaceutical enhancer

KW - Bile salt

KW - 3D human airway in vitro model

KW - MucilAir (TM)

KW - Alternative method

U2 - 10.1016/j.ijpharm.2018.08.031

DO - 10.1016/j.ijpharm.2018.08.031

M3 - Journal article

VL - 550

SP - 114

EP - 122

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -

ID: 209464717